Zachary Vaupel, MD
Orthopaedic Surgery · Royal Oak, MINPI 1356557623
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 50.8% of the total. Reporting peaked in 2019 at $5,148 and has fallen 88.0% since, to $620 in 2025.
Across 45 payments — averaging $372.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$9K
- Stryker$6K
- Pinnacle, Inc$1K
- Paragon 28, Inc.$797
- Johnson & Johnson$290
- Integra Lifesciences Corporation$139
- plus $92 from 4 others
Across 29 payments — averaging $4512.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- DJO, LLC$69K
- Stryker$62K
What the payments were for
- Consulting fees$4,68028%
- Speaking & faculty fees$8,50051%
- Food & beverage$2,36314%
- Education$1,2007%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $8,500 |
| Stryker(2 entities) | 15 | $5,709 |
| Pinnacle, Inc | 2 | $1,217 |
| Paragon 28, Inc. | 15 | $797 |
| Johnson & Johnson | 4 | $290 |
| Integra Lifesciences Corporation | 1 | $139 |
| Smith+Nephew | 2 | $32 |
| Acumed LLC | 1 | $28 |
| Abbott | 1 | $16 |
| Fusion Orthopedics USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARIAX$1,560
- APEX$1,560
- ASNIS$1,560
- INTEGRA$417
- APEX 3D$294
- INFINITY$230
- 7 X 23MM CITRELOCK IMPLANT$180
- INBONE$170
- AXS INFINITY LS$156
- Product Portfolio$146
- SALVATION$143
- INTEGRA DERMAL REGENERATION TEMPLATE$139
- PRIMATRIX$139
- HEALIX KNOTLESS PEEK$113
How this compares
$16,743 in reported general payments places this provider in the 80th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Royal Oak
- Paul FortinRoyal Oak$537K
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- John BlahaAnn Arbor$1.5M
- David MarkelSouthfield$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.